Cannabis labelling and consumer understanding of THC levels and serving sizes.


Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 03 2020
Historique:
received: 07 05 2019
revised: 19 12 2019
accepted: 20 12 2019
pubmed: 12 2 2020
medline: 20 1 2021
entrez: 12 2 2020
Statut: ppublish

Résumé

As part of cannabis legalization in Canada and several US states, regulations specify how THC levels should be labelled on products; however, there is little evidence on the extent to which consumers understand and use THC labelling to inform consumption amounts. The current study was designed to assess comprehension of cannabis-related information including communication of dose and strength of product on different labelling designs among young Canadians. Two experiments were conducted in October 2017 among Canadian youth and young adults aged 16-30 years as part of an online cross-sectional survey (N = 870). Experiment 1 randomized respondents to one of three labelling conditions (1=No Label, 2=mgTHC, 3=Doses). Respondents interpreted a recommended serving and number of servings contained in the package. Experiment 2 randomized respondents to one of four labelling conditions communicating THC level (1=No Label, 2=%THC, 3=mgTHC, 4=Traffic Light System). Respondents determined level of THC in the product. Labelling the number of doses per package was associated with the greatest proportion of correct responses (54.1 %) when respondents had to determine a recommended serving compared with the no-label control condition (7.4 %) and THC mg condition (13.4 %). When cannabis products were labelled using a traffic light system, participants were more likely to identify THC level: low THC (85.1 %) or high THC (86.4 %) than the control condition (2.0 % and 5.2 % respectively). Few consumers can understand and apply quantitative THC labelling; in contrast, THC labels that provide 'interpretive' information, such as descriptors, symbols, or references to servings have greater efficacy.

Identifiants

pubmed: 32044091
pii: S0376-8716(20)30008-9
doi: 10.1016/j.drugalcdep.2020.107843
pii:
doi:

Substances chimiques

Hallucinogens 0
Dronabinol 7J8897W37S

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107843

Subventions

Organisme : CIHR
ID : PJT-153342
Pays : Canada
Organisme : CIHR
ID : FDN-148477
Pays : Canada

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Cesar Leos-Toro (C)

School of Public Health & Health Systems, University of Waterloo, 200 University Ave. W., Waterloo, N2L 3G1, ON, Canada. Electronic address: cesar.leos-toro@uwaterloo.ca.

Geoffrey T Fong (GT)

School of Public Health & Health Systems, University of Waterloo, 200 University Ave. W., Waterloo, N2L 3G1, ON, Canada; Department of Psychology, University of Waterloo, 200 University Ave. W., N2L 3G1, Waterloo, ON, Canada; Ontario Institute for Cancer Research, MaRS Centre, 661 University Avenue, Suite 510, Toronto, M5G 0A3, ON, Canada. Electronic address: geoffrey.fong@uwaterloo.ca.

Samantha B Meyer (SB)

School of Public Health & Health Systems, University of Waterloo, 200 University Ave. W., Waterloo, N2L 3G1, ON, Canada. Electronic address: samantha.meyer@uwaterloo.ca.

David Hammond (D)

School of Public Health & Health Systems, University of Waterloo, 200 University Ave. W., Waterloo, N2L 3G1, ON, Canada. Electronic address: dhammond@uwaterloo.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH